Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seybold, M. E.
Right arrow Articles by Lindstrom, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seybold, M. E.
Right arrow Articles by Lindstrom, J. M.
NEUROLOGY 1981;31:476
© 1981 American Academy of Neurology

Myasthenia gravis in infancy

Marjorie E. Seybold, M.D. and Jon M. Lindstrom, Ph.D.

San Diego VA Medical Center, San Diego, CA, and the Departments of Neurosciences and Surgery, University of California, San Diego (Dr. Seybold) and the Salk Institute for Biological Studies (Dr. Lindstrom), San Diego, CA.

Symptoms of myasthenia gravis in infancy may occur from passive transfer of maternal disease, acquired autoimmune disease, or nonautoimmune hereditary disease. Of nine patients with infantile-onset myasthenia who were not born to mothers with the disease, two had detectable antibody to acetylcholine receptor. Patients with or without antibodies were clinically indistinguishable, except for the occurrence of similar disease in siblings of patients without antibody. Differentiation of autoimmune and hereditary myasthenia in infancy is necessary for appropriate therapeutic measures and genetic counseling. Antibody determinations provide a useful aid in this differentiation.

Address correspondence and reprint requests to Dr. Seybold, (V-1271, San Diego VA Medical Center, 3350 La Jolla Village Drive, San Diego, CA 92161.

This investigation was supported in part by the Veterans Administration.

Accepted for publication July 22, 1980




This article has been cited by other articles:


Home page
J Child NeurolHome page
A. K. Afifi and W. E. Bell
Tests for Juvenile Myasthenia Gravis: Comparative Diagnostic Yield and Prediction of Outcome
J Child Neurol, October 1, 1993; 8(4): 403 - 411.
[Abstract] [PDF]


Home page
J Child NeurolHome page
O. Papazian
Topical Review Article: Transient Neonatal Myasthenia Gravis
J Child Neurol, April 1, 1992; 7(2): 135 - 141.
[Abstract] [PDF]


Home page
CLIN PEDIATRHome page
J. M. Dooley, H. Writer, E. J. Gibson, and J. MacSween
The Clinical Spectrum: A Practical Approach to Diagnosis and Treatment
Clinical Pediatrics, December 1, 1988; 27(12): 575 - 578.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.